258 related articles for article (PubMed ID: 15723079)
1. SUMO modification of the ubiquitin-conjugating enzyme E2-25K.
Pichler A; Knipscheer P; Oberhofer E; van Dijk WJ; Körner R; Olsen JV; Jentsch S; Melchior F; Sixma TK
Nat Struct Mol Biol; 2005 Mar; 12(3):264-9. PubMed ID: 15723079
[TBL] [Abstract][Full Text] [Related]
2. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
3. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
4. Ubc9 sumoylation regulates SUMO target discrimination.
Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
[TBL] [Abstract][Full Text] [Related]
5. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
6. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of ubiquitin conjugating enzyme E2-25K: the tail is a core-dependent activity element.
Haldeman MT; Xia G; Kasperek EM; Pickart CM
Biochemistry; 1997 Aug; 36(34):10526-37. PubMed ID: 9265633
[TBL] [Abstract][Full Text] [Related]
8. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.
Knipscheer P; van Dijk WJ; Olsen JV; Mann M; Sixma TK
EMBO J; 2007 Jun; 26(11):2797-807. PubMed ID: 17491593
[TBL] [Abstract][Full Text] [Related]
9. SUMO: getting it on.
Anckar J; Sistonen L
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
[TBL] [Abstract][Full Text] [Related]
10. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.
Tian S; Poukka H; Palvimo JJ; Jänne OA
Biochem J; 2002 Nov; 367(Pt 3):907-11. PubMed ID: 12144530
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
[TBL] [Abstract][Full Text] [Related]
12. Core domain mutation (S86Y) selectively inactivates polyubiquitin chain synthesis catalyzed by E2-25K.
Mastrandrea LD; Kasperek EM; Niles EG; Pickart CM
Biochemistry; 1998 Jul; 37(27):9784-92. PubMed ID: 9657692
[TBL] [Abstract][Full Text] [Related]
13. An extended consensus motif enhances the specificity of substrate modification by SUMO.
Yang SH; Galanis A; Witty J; Sharrocks AD
EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of E2-25K/UBB+1 interaction leading to proteasome inhibition and neurotoxicity.
Ko S; Kang GB; Song SM; Lee JG; Shin DY; Yun JH; Sheng Y; Cheong C; Jeon YH; Jung YK; Arrowsmith CH; Avvakumov GV; Dhe-Paganon S; Yoo YJ; Eom SH; Lee W
J Biol Chem; 2010 Nov; 285(46):36070-80. PubMed ID: 20826778
[TBL] [Abstract][Full Text] [Related]
15. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
Reverter D; Lima CD
Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
[TBL] [Abstract][Full Text] [Related]
16. Preparation of sumoylated substrates for biochemical analysis.
Knipscheer P; Klug H; Sixma TK; Pichler A
Methods Mol Biol; 2009; 497():201-10. PubMed ID: 19107419
[TBL] [Abstract][Full Text] [Related]
17. Versatile protein tag, SUMO: its enzymology and biological function.
Kim KI; Baek SH; Chung CH
J Cell Physiol; 2002 Jun; 191(3):257-68. PubMed ID: 12012321
[TBL] [Abstract][Full Text] [Related]
18. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.
Bossis G; Melchior F
Mol Cell; 2006 Feb; 21(3):349-57. PubMed ID: 16455490
[TBL] [Abstract][Full Text] [Related]
19. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
Truong K; Lee TD; Chen Y
J Biol Chem; 2012 May; 287(19):15154-63. PubMed ID: 22403398
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
